ASP Isotopes financials
$2.64+1.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $23.8M | $4.1M | $433.0K | $0.00 |
| Gross profit | $3.4M | $1.6M | $139.0K | $0.00 |
| Gross margin | 14.3% | 38.6% | 32.1% | — |
| Operating income | -$59.9M | -$26.4M | -$16.0M | -$5.1M |
| Net income | -$175.1M | -$35.1M | -$16.3M | -$4.9M |
| Net margin | −734.2% | −847.3% | −3761.0% | — |
| Diluted EPS | $-2.11 | $-0.63 | $-0.49 | $-0.18 |
| EBITDA | -$58.0M | -$25.9M | -$16.0M | -$5.1M |
| Operating cash flow | -$37.8M | -$16.7M | -$5.4M | -$2.9M |
| Free cash flow | -$47.4M | -$28.1M | -$7.7M | -$7.4M |
| Diluted shares | 83.0M | 55.7M | 33.1M | 26.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $279.6M | $61.9M | $7.9M | $2.4M |
| Short-term investments | $47.7M | $0.00 | $0.00 | $0.00 |
| Total debt | $202.0M | $36.5M | $739.4K | $33.9K |
| Total assets | $498.0M | $94.3M | $27.5M | $12.5M |
| Total liabilities | $235.1M | $43.2M | $8.7M | $2.7M |
| Shareholders' equity | $262.9M | $51.2M | $18.8M | $9.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology